Background {#Sec1}
==========

Acute respiratory distress syndrome (ARDS) is a form of acute respiratory failure characterized by pulmonary inflammation leading to increased capillary and epithelial permeability, with subsequent loss of aerated lung tissue and increased lung stiffness \[[@CR1]\]. These alterations lead to imbalances between ventilation and perfusion relationships, which finally result in hypoxemia and impaired carbon dioxide clearance.

An optimal ventilation-to-perfusion (*V*~A~/*Q*) ratio (0.1 \< *V*~A~/*Q* \< 10) is necessary to ensure a normal gas exchange \[[@CR2]--[@CR4]\]. Typically, it has been considered that pulmonary perfusion in ARDS occurs in non-ventilated (*V*~A~/*Q* \< 0.005) or poorly ventilated (0.005 \< *V*~A~/*Q* \< 0.1) lung units, which, in turn, results in vasoconstriction of perfusing arterioles \[[@CR5]\]. Such *V*~A~/*Q* mismatch in some lung regions in which perfusion largely exceeds ventilation, account for hypoxemia, which is the clinical hallmark of ARDS \[[@CR1], [@CR6], [@CR7]\]. Nevertheless, distribution of ventilation to poorly perfused (10 \< *V*~A~/*Q* \< 100), severely hypoperfused (*V*~A~/*Q* \> 100) or non-perfused (*V*~A~/*Q* \~ ∞) lung units might also occur in patients with ARDS \[[@CR3]\] and indeed, increases in *V*~D~/*V*~T~ have been strongly related with adverse clinical outcomes \[[@CR8]--[@CR10]\]. Importantly, high *V*~A~/*Q* and *V*~A~/*Q* \~ ∞ ratios corresponding to lung regions where ventilation largely exceeds perfusion, account for carbon dioxide retention \[[@CR5]\]. Increases in high *V*~A~/*Q* and/or dead-space lung units have been classically attributed to alveolar overdistention with the subsequent compression of intra-alveolar vessels in the non-dependent lung areas \[[@CR8], [@CR11]\]. Nevertheless, increased dead-space ventilation has also been described in patients subjected to protective ventilation strategies with low plateau pressures \[[@CR9], [@CR10]\], which suggest that mechanisms different to alveolar overdistention should be implied.

In normal conditions, the heterogeneity of systemic microcirculatory blood flow distribution is negligible \[[@CR12]\]. Nevertheless, severe inflammation can induce microcirculatory alterations \[[@CR13], [@CR14]\] determining alterations in oxygen extraction capabilities by the tissues and contributing to the development of multiple organ dysfunction \[[@CR14]\]. Although there are many technical limitations to directly evaluate pulmonary microcirculation \[[@CR15]\], heterogeneity of microvascular blood flow at pulmonary level could contribute to imbalances between ventilation and perfusion relationships. Thus, considering microcirculatory dysfunction during inflammatory conditions as a generalized phenomenon, which may involve systemic and pulmonary vascular beds, we hypothesized that alterations in microvascular blood flow distribution evaluated at the sublingual mucosa as representative of an extra-pulmonary territory could be related to variations in dead-space ventilation *V*~D~/*V*~T~ during early phases of moderate and severe ARDS.

Methods {#Sec2}
=======

This prospective observational study was conducted in a 90-bed mixed ICU from a university hospital. The local Ethical and Biomedical Research Committee approved the study (Fundación Valle del Lili EBRC protocol number: 0628; approval number: 038-7, 2013). A written informed consent was waived as no invasive procedures or new interventions were used. We daily screened all patients under mechanical ventilation in the ICU during a 24-month period, searching for those with moderate and severe ARDS. To avoid the selection of cases with transitory hypoxemia simulating ARDS, patients were enrolled only after successfully completing a two-step selection process \[[@CR16], [@CR17]\]: (a) first, patients mechanically ventilated through an endotracheal tube with a PEEP ≥ 5 and FiO~2~ ≥ 0.5 for at least 12 h and meeting the moderate and severe ARDS criteria according to Berlin Consensus definitions \[[@CR1]\] were declared potentially eligible; (b) then, potential candidates were subjected to a FiO~2~ trial at 1.0 while maintaining PEEP ≥ 10 (to sustain a SpO~2~ ≥ 88%, but ensuring peak inspiratory and plateau pressures \< 35 and 28 cmH~2~O, respectively) for at least 30 min, after which, new arterial blood gases were collected. Those patients maintaining a PaO~2~/FiO~2~ ≤ 200 after such PEEP/FiO~2~ trial and with \< 48 h of evolution of ARDS were finally included. The exclusion criteria were: \< 18 years of age, pregnancy state, history of neuromuscular diseases, moderate and severe COPD (defined as FEV~1~ \< 80% predicted); history of intubation due to COPD exacerbation, receiving domiciliary oxygen or long-term use of steroids because COPD; history of congestive heart failure or any acute ischemic cardiac condition. A patient was also excluded when limitation of therapeutic effort orders were given.

Study protocol {#Sec3}
--------------

After fulfilling the two-step selection process, patients selected were connected to a mainstream CO~2~ sensor and this in turn to a volumetric capnography module (Infinity EtCO~2~ + respiratory mechanics module, Dräger Medical Systems, Telford, USA). Mechanical ventilation parameters were adjusted after a stepwise alveolar recruitment maneuver, as it will be detailed later. After a 60 min of stabilization period, we started capnography measurements while sublingual microcirculatory images were simultaneously acquired, such as detailed thereafter. A new set of measurements was obtained 24 h after. Arterial and mixed venous blood samples (when available) were drawn for gases analysis (ABL300, Radiometer; Copenhagen, Denmark) at T0 and 24 h after (T24). In all the cases, the attending physicians decided on the type of hemodynamic monitoring to use. Complete respiratory and hemodynamic parameters were also registered simultaneously.

Recruitment maneuvers, PEEP adjustment and mechanical ventilation settings {#Sec4}
--------------------------------------------------------------------------

At the time in which this study was performed, the local protocol included an initial recruitment maneuver to adjust PEEP in patients with severe ARDS. Thus, patients were subjected to a stepwise recruitment maneuver with progressive PEEP increases until a peak pressure of 50 cmH~2~O while maintaining a driving pressure of 15 cmH~2~O, as described elsewhere \[[@CR18], [@CR19]\]. Once obtained the maximal peak pressure, it was sustained during 2 min whereupon a decremental PEEP titration trial was conducted in steps of 2 cmH~2~O at 2 min interval from 22 to 8 cmH~2~O registering the corresponding compliance of the respiratory system (*C*~RS~). After such a PEEP titration, a new alveolar recruitment was performed until a peak pressure of 50 cmH~2~O while maintaining a driving pressure of 15 cmH~2~O during 1 min, to finally adjust the definitive ventilatory settings. Definitive PEEP was set at the corresponding best *C*~RS~ plus 2 cmH~2~O. If falls in C~RS~ were observed in two consecutive downsteps, then the PEEP level was set at the highest compliance plus 2 cmH~2~O. According to the local protocol, the recruitment maneuver was stopped if one or more of following signs were observed: heart rate \> 150 or \< 60 bpm; decrease of mean arterial pressure \< 65 mmHg or systolic pressure \< 90 mmHg; acute atrial fibrillation, atrial flutter or ventricular tachycardia.

Thereafter, mechanical ventilation was set in volume-controlled mode or in pressure-controlled, according to the selection of the attending physician. In the first case, ventilation was set at Vt of 6 ml/kg of predicted body weight maintaining plateau pressures \< 28 cmH~2~O, flow of 60 l/min, inspiratory pause of 0.5 s, *I*:*E* ratio of 1:1 to 1:2, respiratory rate to match the minute ventilation previous to the recruitment maneuver, FiO~2~ necessary for SpO~2~ ≥ 90 and ≤ 95% and PEEP adjusted as indicated above. If plateau pressures were \> 28 cmH~2~O, then Vt was reduced to a minimum of 4 ml/kg of predicted body weight. For those ventilated in pressure-controlled mode, driving pressure was adjusted to maintain Vt 6 ml/kg of predicted body weight (or less if Vt/*C*~RS~ \> 18), *I*:*E* ratio 1:1 to 1:2, minute ventilation matching that previous to the recruitment maneuver, peak inspiratory pressure ≤ 35 cmH~2~O, and FiO~2~ and PEEP adjusted as indicated above.

Pulmonary dead-space fraction measurements {#Sec5}
------------------------------------------

After an automatic purge and calibration procedure, a mainstream CO~2~ sensor was placed between the ventilator circuit and the patient connection. This sensor was in turn connected to a volumetric capnography module (Infinity EtCO~2~ + respiratory mechanics module, Dräger Medical Systems, Telford, USA). After selection of the ventilator settings, a 60 min of stabilization period was allowed before to start the measurements. Data trend for CO~2~ production ($\documentclass[12pt]{minimal}
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Sublingual microcirculation assessment {#Sec6}
--------------------------------------

A sidestream dark-field (SDF) imaging device (Micro Scan; MicroVision Medical, Amsterdam, the Netherlands) was used to explore the sublingual microcirculation simultaneously to dead-space fraction measurements, ventilatory mechanics and oxygenation parameters at both inclusion and 24 h after. A cutoff value of 20 μm was used to classify vessels as large or small. Continuous flows were considered as normal while intermittent and stopped flows were considered as abnormal. According to the consensus for the evaluation of microcirculation, we calculated the proportion of small vessels perfused (PPV), the total vascular density (TCD) and the functional capillary density (FCD) \[[@CR21]\]. A heterogeneity index of microcirculatory blood flow was also calculated as the difference between maximal and minimal PPV values in five different mucosa areas divided by its own mean value (see Additional file [1](#MOESM1){ref-type="media"}). Additionally, we reported the microvascular flow index (MFI). A detailed description about microcirculatory blood flow assessment is provided in Additional file [1](#MOESM1){ref-type="media"}.

Statistical analysis {#Sec7}
--------------------

Sample size calculation is described in Additional file [1](#MOESM1){ref-type="media"}. Distribution of data was tested using the Kolmogorov--Smirnov test. Non-parametric test for related samples were used to evaluate the differences on hemodynamic, respiratory, capnometry and microcirculatory blood flow parameters between baseline and 24 h after. The relationships between the *V*~D~/*V*~T~, percentage of small vessels perfused (PPV), and microcirculatory blood flow index (MFI) were evaluated by the Spearman rho test. Other bivariate correlations between *V*~D~/*V*~T~, PaO~2~/FiO~2~, and respiratory mechanics were also performed using Spearman rho test. Additionally, simple linear regression models with linear and quadratic terms and their respective coefficients of determination (*R*^2^) were used to evaluate the relationship between each microcirculatory, respiratory mechanics or oxygenation parameter and the *V*~D~/*V*~T~ at both baseline and 24 h after.

Finally, we calculated the delta of variation of *V*~D~/*V*~T~ and PPV measurements between baseline and 24 h after. Then, a Spearman rho was used to evaluate the correlation between *V*~D~/*V*~T~ and PPV dynamic variations from baseline to day-1. Furthermore, a simple linear regression model with quadratic term and its respective coefficient of determination (*R*^2^) was used to evaluate the relationship between variations in PPV and *V*~D~/*V*~T~ from baseline to 24 h after. Data are presented as median \[percentiles 25--75\]. A *p* value ≤ 0.05 (2-tailed) was considered significant.

Results {#Sec8}
=======

A total of 42 patients with moderate and severe ARDS were included in the study. A complete flowchart detailing the selection process is shown in Additional file [1](#MOESM1){ref-type="media"}: Figure S1, while a STROBE statement checklist for observational studies is provided in Additional file [1](#MOESM1){ref-type="media"}: Table S1. Mortality at day-28 and day-90 were 31% and 45.2%, respectively. The ICU length of stay was 18.0 \[11.8--26.3\] days. General characteristics are presented in Table [1](#Tab1){ref-type="table"}, while hemodynamics, respiratory mechanics, blood gases analysis, pulmonary dead-space fraction and microcirculatory blood flow parameters at baseline and 24 h after are presented in Table [2](#Tab2){ref-type="table"}. We observed an inverse and significant relationship between PPV and *V*~D~/*V*~T~ at both baseline (Spearman rho = − 0.76, *p* \< 0.001; *R*^2^ = 0.63, *p* \< 0.001) and 24 h after (Spearman rho = − 0.71, *p* \< 0.001; *R*^2^ = 0.66, *p* \< 0.001) (Fig. [1](#Fig1){ref-type="fig"}a, b). Similar findings were observed between *V*~D~/*V*~T~ and the microcirculatory flow index at baseline (Spearman rho = − 0.63, *p* \< 0.001; *R*^2^ = 0.48, *p* \< 0.001) and 24 h after (Spearman rho = − 0.65, *p* \< 0.001; *R*^2^ = 0.60, *p* \< 0.001) (Fig. [1](#Fig1){ref-type="fig"}c, d). There were no significant correlations between *V*~D~/*V*~T~ and other respiratory mechanics and oxygenation parameters (Fig. [2](#Fig2){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Table S2).Table 1General characteristicsAll patientsAge48 (33--63)Sex, male (%)24 (57.1)APACHE II21.5 (17.0 27.3)SOFA, day 111.0 (7.8--13.3)Coexisting conditions Hypertension8 (19.0) Diabetes5 (11.9) Hepatic disease5 (13.2) Chronic renal failure3 (7.3) Cancer6 (14.3) Immunosuppression6 (14.3) BMI (kg/m^2^)20.7 (20.3--22.7)Risk factors for ARDS Sepsis28 (66.7) Trauma5 (13.2) Pneumonia13 (34.2) Gastric aspiration6 (15.8) Other11 (28.9) Vasopressors, *n* (%)26 (61.9) Steroids, *n* (%)15 (35.7) TRR, *n* (%)8 (19.5) Prone position, *n* (%)10 (23.8) Muscular paralysis34 (80.9) Time since ICU admission to ARDS onset, hours96 (24--168) Cumulated resuscitation fluids, ml2.300 (1.075--4.735) Total cumulative fluids at ARDS diagnosis, ml6.361 (2.182--13.023)Mortality At day 2813 (31.0) At day 9019 (45.2)Table 2Hemodynamics, respiratory mechanics, blood gases analysis, $\documentclass[12pt]{minimal}
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                \begin{document}$$V_{{{\text{CO}}_{2} }}$$\end{document}$, *V*~D~/*V*~T~ and microcirculatory parameters at baseline and 24 h afterBaseline24 h*p*Hemodynamics HR, bpm104 (94--121)100 (89--115)0.43 MAP, mmHg74 (69--87)75 (67--92)0.35 CVP, mmHg, n12 (8--14)12 (7--14)0.96 PAOP, mmHg, n14 (12--16), 2219 (16--22), 240.03 PAPm, mmHg, n36 (42--46), 2230 (26--41), 240.13 PVR, dyn.s/cm^5^, n298 (250--440), 22299 (211--360), 240.86 Cardiac index, (l/min/m^2^), *n*4.2 (3.4--4.5), 223.9 (3.5--4.4), 240.30 Norepinephrine, (ugr/kg/min), *n*0.10 (0.05--0.27), 180.05 (0.03--0.34), 180.09Respiratory mechanics and blood gases *V*~T~, ml369 (325--415)363 (312--404)0.56 *V*~T~, ml/kg6.5 (6.1--6.9)6.6 (6.4--6.9)0.56 RR24 (20--26)25 (22--27)0.17 PEEP12 (10--15)12 (10--14)0.07 *P*~Peak~30 (27--33)29 (26--34)0.57 Pm~aw~19 (14--21)18 (15--20)0.36 *V*~T~/*C*~RS~17 (14--19)16 (14--18)0.42 pH7.28 (7.21--7.32)7.35 (7.26--7.39)\< 0.001 PaO~2~, mmHg79.1 (69.7--95.5)86.6 (72.6--109.2)0.06 PaCO~2~, mmHg46.6 (39.9--56.3)42.3 (34.6--47.6)0.003 HCO~3~, mmol/L20.9 (19.1--24.2)20.7 (17.8--26.5)0.78 BE, mmol/L− 6.4 (− 8.8 to − 2.3)− 5.9 (− 8.4 to − 0.05)0.03 PaO~2~/FiO~2~119 (93--148)173 (124--222)\< 0.001 PvO~2~, mmHg48.7 (42.3--54.1)40.8 (36.9--47.6)0.004 PvCO~2~, mmHg48.2 (41.6--59.3)44.6 (36.1--53.6)0.003 ScvO~2~,  %78.0 (70.9--80.9)75.2 (62.3--81.7)0.17Capnography/expired CO~2~ $\documentclass[12pt]{minimal}
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                \begin{document}$$F_{{{\text{ECO}}_{2} }}$$\end{document}$: exhaled carbon dioxide fraction; *V*~TE~: exhaled tidal volume; *V*~D~/*V*~T~: pulmonary dead-space fraction; PPV: percentage of small vessels perfused; LVP: percentage of large vessels perfused; FCD: functional capillary density; TCD: total capillary density; MFI: microvascular blood flow indexFig. 1Relationships between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the microcirculatory blood flow at baseline and 24 h after. **a** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the proportion of small vessels perfused at baseline. **b** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the proportion of small vessels perfused 24 h after. **c** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and MFI at baseline. **d** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and MFI 24 h after. PPV: percentage of small vessels perfused; *V*~D~*/V*~T~: pulmonary dead-space fraction; HI: heterogeneity index of microcirculatory blood flow; MFI: microcirculatory blood flow indexFig. 2Relationships between pulmonary dead-space fraction (*V*~D~/*V*~T~) and some respiratory mechanics and oxygen parameters at baseline and 24 h after. **a** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the PaO~2~/FiO~2~ ratio at baseline. **b** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the PaO~2~/FiO~2~ ratio 24 h after. **c** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and PEEP levels at baseline. **d** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and PEEP levels 24 h after. **e** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the *V*~T~/*C*~RS~ at baseline. **f** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and the *V*~T~/*C*~RS~ 24 h after. **g** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and Pm~aw~ at baseline. **h** Scatter plot depicting the correlation between pulmonary dead-space fraction (*V*~D~/*V*~T~) and Pm~aw~ 24 h after. PaO~2~/FiO~2~ ratio: arterial oxygen partial pressure to oxygen inspiratory fraction; PEEP: positive end-expiratory pressure; *V*~T~/*C*~RS~: tidal volume-to-respiratory system compliance ratio (i.e., driving pressure); Pm~aw~: mean pressure of the airway

A significant relationship was observed between the variation in *V*~D~/*V*~T~ and the percentage of variation of PPV from baseline measurements to 24 h after (Spearman rho = − 0.66, *p* \< 0.001; *R*^2^ = 0.67, *p* \< 0.001) (Fig. [3](#Fig3){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Figure S2). Additional information about survivors and non-survivors at day-90 is provided in Additional file [1](#MOESM1){ref-type="media"}: Table S3.Fig. 3Relationships between dynamic variations in pulmonary dead-space fraction (*V*~D~/*V*~T~) and microcirculatory blood flow. Scatter plot depicting the correlation between variations in pulmonary dead-space fraction (Δ-*V*~D~/*V*~T~) vs. percentage of change in small vessels perfused (Δ-PPV) between baseline and 24 h after

Discussion {#Sec9}
==========

After simultaneous calculation of dead-space fraction by volumetric capnography and exploration of sublingual microcirculation by the SDF technique during the early stages of moderate and severe ARDS, we retrieved two hypothesis-generating observations: (a) *V*~D~/*V*~T~ is inverse and significantly related with sublingual microcirculatory blood flow distribution, while PEEP levels, respiratory airway pressures, PaO~2~/FiO~2~ and lung strain surrogates (*V*~T~/*C*~RS~) do not; (b) *V*~D~/*V*~T~ variations were closely related with dynamic changes in the microcirculatory blood flow distribution observed at sublingual mucosa.

Other mechanisms unrelated to shunt-induced hypoxemia could be implicated in gas exchange abnormalities and in the onset of pulmonary and extra-pulmonary multiorgan dysfunction in ARDS. Distribution of ventilation to poorly perfused (10 \< *V*~A~/*Q* \< 100), severely hypoperfused (*V*~A~/*Q* \> 100) or non-perfused, i.e., true dead-space ventilation (*V*~A~/*Q* \~ ∞) lung units, can also contribute to gas exchange disturbances and it might be a key piece in the pathophysiology of ARDS. Some studies in the past demonstrated the occurrence of increased pulmonary dead-space fraction in patients with acute hypoxemic respiratory failure \[[@CR3], [@CR22], [@CR23]\], and highlighted the apparent relationship between high *V*~D~/*V*~T~ and increased mortality \[[@CR8]\]. Nevertheless, early studies included patients under non-lung-protective ventilation strategies, in which over-inflation leading to capillary collapse could explain *V*~A~/*Q* mismatching with the resultant increased *V*~D~/*V*~T~ \[[@CR24]\]. Remarkably, later studies in ARDS patients subjected to lung-protective ventilation, also demonstrated the occurrence of increases in *V*~D~/*V*~T~ and confirmed its consistent relationship with worse clinical outcomes \[[@CR9], [@CR10], [@CR25]\]. In agreement with this, we observed increases in *V*~D~/*V*~T~ at baseline and 24 h after in patients with moderate and severe ARDS. Importantly, we did not find any relationship between *V*~D~/*V*~T~ and variables suggesting vascular collapse related to alveolar overdistention or increased pulmonary strain (e.g., *V*~T~/*C*~RS~), although admittedly, controlling airway pressures and *V*~T~/*C*~RS~ (driving pressure) could not prevent alveolar overdistention because the inhomogeneous lung compromise in ARDS \[[@CR26]\].

Relationships between microvascular blood flow and *V*~D~/*V*~T~ have not been widely studied because of technical limitations to directly evaluate pulmonary microcirculation \[[@CR15]\]. Our data suggest an apparent relationship between microcirculatory dysfunction and dead-space ventilation. Admittedly, sublingual mucosa and pulmonary circulation are two dissimilar vascular beds with particular regulating mechanisms. Nevertheless, during inflammatory conditions, microcirculatory dysfunction is a generalized phenomenon involving simultaneously most vascular beds \[[@CR14]\], although with different effects depending on the territory studied \[[@CR27]\]. Microcirculatory alterations have been described in autopsies and biopsies from lungs of patients with acute hypoxemic respiratory failure \[[@CR28], [@CR29]\] and angiograms performed through pulmonary artery catheters demonstrated filling defects attributable to macro- and micro-emboli \[[@CR30], [@CR31]\]. Increases in *V*~D~/*V*~T~ in our patients were well correlated with alterations in microcirculatory blood flow distribution detected in a non-pulmonary vascular bed. Such observation could pose the hypothesis about heterogeneity of microvascular blood flow contributing to inequalities in *V*~A~/*Q* relationships. Indeed, variations of *V*~D~/*V*~T~ from baseline to 24 h after were closely related with dynamic changes in microcirculatory blood flow distribution at sublingual mucosa, which reinforce the strength of such relation. Nevertheless, whether pulmonary microvascular alterations or other organ-specific microvascular blood flow can be evaluated or estimated through evaluation of an extra-pulmonary microvascular bed can result highly controversial \[[@CR15]\].

In normal conditions, heterogeneity of microvascular blood flow is negligible \[[@CR12]\] and matching of perfusion to metabolism usually improves during hypoxic or low-flow states \[[@CR32]\]. However, during inflammatory conditions, heterogeneity of microcirculation increases as consequence of the interruption of blood flow of individual capillaries causing derangements in the oxygen extraction capabilities, thus contributing to organ failure. In agreement with this, we observed important microcirculatory alterations consisting in decreased PPV, reduced FCD and increased heterogeneity of blood flow, which were in turn linked to more severe extra-pulmonary organ dysfunction quantified by SOFA score (see Additional file [1](#MOESM1){ref-type="media"}: Table S3).

Pathophysiological mechanisms increasing *V*~D~/*V*~T~ in ARDS are quite complex. An increased *V*~D~/*V*~T~ reflects a global assessment of abnormal gas exchange, but not simply the contribution of discrete high *V*~A~/*Q* regions and true anatomic dead space (*V*~A~/*Q* \~ ∞). Although the patchy pattern of vascular damage is a phenomenon clearly recognized in ARDS \[[@CR26]\], no studies demonstrated that damaged areas necessarily receive substantial ventilation, as would be necessary to explain regions of high *V*~A~/*Q* ratio. Using the multiple inert gas elimination technique (MIGET) to evaluate the fractional contribution of each *V*~A~/*Q* abnormality (shunt, mid-range *V*~A~/*Q* heterogeneity, high *V*~A~/*Q*, and anatomic dead space) on total *V*~D~/*V*~T~ at progressively high PEEP levels, Coffey et al. \[[@CR33]\] demonstrated similar *V*~D~/*V*~T~ values at different PEEP levels mediated by very different physiologic abnormalities, although certainly, higher PEEP values were consistently related to high *V*~A~/*Q* peaks. Our results might add more complexity to the pathophysiology on increased *V*~D~/*V*~T~ in ARDS suggesting the contribution of altered microcirculatory blood flow distribution on the increase of high *V*~A~/*Q* units.

Routine assessment of pulmonary gas exchange in ARDS is based on analysis of oxygen and carbon dioxide partial pressures. These variables, although sensitive to intrapulmonary factors (e.g., shunt and *V*~A~/*Q* matching), could be also altered by extra-pulmonary elements such as cardiac output, oxygen consumption, minute ventilation and inspired oxygen fraction.

*V*~D~/*V*~T~ values can widely vary according to the method used to estimate it \[[@CR34]\]. Previous studies used the Enghoff modification of the Bohr equation (VD~Enghoff~) in patients with ARDS \[[@CR8]--[@CR10], [@CR25]\]. Nevertheless, this method could overestimate the real *V*~D~/*V*~T~ when anatomic or intrapulmonary shunts are present as it assumes a perfect *V*~A~/*Q* matching throughout all alveolar--capillary units \[[@CR35], [@CR36]\]. Although we used the VD~Enghoff~ method, we computed *V*~D~/*V*~T~ from the CO~2~ production ($\documentclass[12pt]{minimal}
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                \begin{document}$$F_{{{\text{ECO}}_{2} }}$$\end{document}$) measurements by volumetric capnography, which can accurately reflect measurements by metabolic monitors \[[@CR20]\].

Trying to exclude cases with transitory hypoxemia simulating ARDS, we completed a two-step selection previously described \[[@CR16], [@CR17]\]. Although breathing pure oxygen may influence the *V*~A~/*Q* distribution \[[@CR5]\], our definitive *V*~D~/*V*~T~ measurements were performed 60 min after return to the previous FiO~2~, thus causing the lowest impact on *V*~A~/*Q* balance. Also, we used a stepwise recruitment maneuver with progressive PEEP increases, which was part of the local protocol at the time in which patients were included. Probably at present, such maneuver would not be used as recent evidence suggests that it can be harmful \[[@CR37]\]. Nevertheless, such maneuver allowed us to standardize the selection of PEEP and ventilatory parameters.

We recognize that our study has important limitations. First, many hemodynamic and respiratory coexisting factors can influence *V*~D~/*V*~T~ measurements. Indeed, combination of hypovolemia, vasoactive agents and/or inotropics, cardiac output variations, pulmonary resistances and flows, distribution of ventilation along the lungs and even local microthrombi formation, might influence *V*~D~/*V*~T~ variations in one or other direction. Thereby, identical *V*~D~/*V*~T~ elevations might reflect simultaneous alterations in diverse physiological components. Second, our study is not able to demonstrate a causal association between *V*~D~/*V*~T~ and sublingual microcirculation and it was not registered as observational study. Nevertheless, dynamic variations from baseline to 24 h after merit exploration in future studies. Third, whether pulmonary microvascular alterations occur in parallel to other extra-pulmonary microvascular beds is highly controversial. However, microcirculation studies reveal simultaneous alterations at different beds during shock or inflammatory conditions. Fourth, the number of cases included in our study was relatively small. However, the fact that our patients were strictly selected and calculation of *V*~D~/*V*~T~ used $\documentclass[12pt]{minimal}
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Conclusion {#Sec10}
==========

Increased heterogeneity of microcirculatory blood flow evaluated at sublingual mucosa seems to be related to increases in *V*~D~/*V*~T~ independently of respiratory mechanics and oxygen parameters, thus suggesting that microcirculatory alterations could be implicated in ventilation/perfusion mismatching during early ARDS.

The inverse dynamic relationships observed between sublingual microcirculation and dead-space ventilation poses a hypothetical pathophysiological mechanism during moderate and severe ARDS that deserves future research efforts.
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**Additional file 1.** Microcirculatory assessement.

ARDS

:   Acute respiratory distress syndrome

CO~2~

:   Carbon dioxide

COPD

:   Chronic obstructive pulmonary disease

*C*~RS~

:   Compliance of the respiratory system

EtCO~2~

:   End-tidal CO~2~

FCD

:   Functional capillary density
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:   Exhaled CO~2~ fraction

MFI

:   Microcirculatory flow index
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:   Exhaled CO~2~ pressure

PEEP

:   Positive end-expiratory pressure

PPV

:   Percentage of small-vessels perfused

TCD

:   Total capillary density

*V*~A~/*Q*

:   Ventilation-to-perfusion ratio
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:   CO~2~ production

*V*~D~/*V*~T~

:   Dead-space ventilation fraction

*V*~E~

:   Exhaled minute ventilation

*V*~T~

:   Tidal volume

*V*~T~/*V*~RS~

:   Driving pressure
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